New combo therapy shows promise in tough pancreatic cancer
NCT ID NCT04257448
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new treatment plan for people with advanced pancreatic cancer that has spread. It combined chemotherapy with drugs that change how genes work and boost the immune system. The goal was to see if this approach is safe and can help control the disease. 75 patients took part in this early-phase trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Klinikum Nürnberg
Nuremberg, 90419, Germany
-
Ludwig-Maximilians-Universität München
München, 81377, Germany
-
Uniklinik Köln
Cologne, 50937, Germany
-
Universitätsklinikum Essen
Essen, 45147, Germany
-
Universitätsklinikum Frankfurt
Frankfurt, 60590, Germany
-
Universitätsklinikum Hamburg-Eppendorf
Hamburg, 20251, Germany
-
Universitätsklinikum Ulm
Ulm, 89081, Germany
-
Universitätsklinikum Würzburg
Würzburg, 97080, Germany
-
Universitätsmedizin Göttingen
Göttingen, 37075, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Blood and gut clues may flag pancreatic cancer risk early
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a pill outsmart Tumors' defenses?
- Can a pill rouse the immune system against pancreatic cancer?
- Can a new ultrasound technique spot hidden pancreatic cancers earlier?